Key result
Antiplatelet agents, including aspirin, aspirin/dipyridamole, and clopidogrel, are the recommended first-line therapies for secondary ischemic stroke prevention.
Why the study?
What are the recommended antiplatelet therapies for secondary stroke prevention?
Population
Patients requiring secondary stroke prevention
Design
Review
Authors
Loading...
Affirms antiplatelet use as standard in secondary stroke prevention for clinicians; leaves open comparative trials of newer agents.
What are the recommended antiplatelet therapies for secondary stroke prevention?
Antiplatelet agents such as aspirin, aspirin/dipyridamole, and clopidogrel remain the mainstays of secondary ischemic stroke prevention.
Crawford et al. (2001) conducted a review in Secondary stroke prevention. Antiplatelet agents was evaluated. Antiplatelet agents, including aspirin, aspirin/dipyridamole, and clopidogrel, are the recommended first-line therapies for secondary ischemic stroke prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: